(Q73794766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Y Tsubouchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H Sano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Yamada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Hashiramoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Kohno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Kusaka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Kondo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

255-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Inducible cyclooxygenase (COX-2): a safer therapeutic target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Utilization of nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Meloxicam inhibits the growth of colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Clinical pharmacology of platelet cyclooxygenase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Prostaglandin endoperoxide H synthases-1 and -2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Inhibition by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Aspirin use and reduced risk of fatal colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

The Use of Aspirin in Ischemic Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900163-1

10.1016/S0014-2999(00)00163-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812057%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference